A carregar...
The protective effect of rheumatic disease agents in COVID-19
Several immunosuppressive therapies have been investigated as potential treatments for patients with severe and critical coronavirus disease 2019 (COVID-19). Notable examples include corticosteroids, interleukin 6 (IL-6), interleukin 1 (IL-1), Janus kinase (JAK), and tumor necrosis factor alpha (TNF...
Na minha lista:
| Publicado no: | Best Pract Res Clin Rheumatol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier Ltd.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7833968/ https://ncbi.nlm.nih.gov/pubmed/33526326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.berh.2021.101659 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|